e-learning
resources
Barcelona 2010
Wednesday, 22.09.2010
Biomarkers and diagnosis of allergic inflammatory diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Osteopontin expression and relation to disease severity in human asthma
K. Samitas, E. Zervas, S. Vittorakis, A. Bossios, E. Economidou, J. Lötvall, G. Xanthou, V. Panoutsakopoulou, M. Gaga (Athens, Greece; , Sweden)
Source:
Annual Congress 2010 - Biomarkers and diagnosis of allergic inflammatory diseases
Session:
Biomarkers and diagnosis of allergic inflammatory diseases
Session type:
Oral Presentation
Number:
5358
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Samitas, E. Zervas, S. Vittorakis, A. Bossios, E. Economidou, J. Lötvall, G. Xanthou, V. Panoutsakopoulou, M. Gaga (Athens, Greece; , Sweden). Osteopontin expression and relation to disease severity in human asthma. Eur Respir J 2010; 36: Suppl. 54, 5358
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
The role of IL-18 level and genetic polymorphism in patients with bronchial asthma and its relation to disease severity
Source: Annual Congress 2012 - Gene-environment treatment and asthma
Year: 2012
DPP10 protein expression is associated with the pathogenesis of asthma and COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 231s
Year: 2005
Osteopontin expression and relation to disease severity in human asthma
Source: Eur Respir J 2011; 37: 331
Year: 2011
Upregulation of interleukin-19 in severe asthma: a potential saliva biomarker for asthma severity
Source: ERJ Open Res, 7 (3) 00984-2020; 10.1183/23120541.00984-2020
Year: 2021
Ykl-40, CHI3L1, their relationship and role in asthma
Source: Annual Congress 2010 - Genetics of asthma
Year: 2010
Airway epithelial toll-like receptor expression in asthma and its relationship to disease severity
Source: Annual Congress 2011 - Immunology and cell biology of asthma and COPD
Year: 2011
SP-A and CC-16 expression in COPD patient: correlation with stage of severity and possible pathogenetic role
Source: Eur Respir J 2003; 22: Suppl. 45, 77s
Year: 2003
Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013
The relationship between bronchial inflammation and markers of disease progression in COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 179s
Year: 2003
The relationship between the severity of childhood asthma and leptin levels
Source: Annual Congress 2007 - Risk factors for childhood asthma: cohort studies
Year: 2007
Periostin as a marker of Th2-related inflammation in patients with different types of chronic obstructive airway disease
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017
Expression of the β2-adrenoreceptor and M3-cholinoreceptor genes in patients with different severity of asthma and BHR level
Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma
Year: 2012
Late Breaking Abstract - Increased serum levels of YKL-40 in male smoking chronic obstructive pulmonary disease patients associated with altered miRNA levels in alveolar macrophages
Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases
Year: 2020
Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients
Source: ERJ Open Res, 5 (2) 00021-2019; 10.1183/23120541.00021-2019
Year: 2019
Sputum MMP-12 concentration and enzyme activity in COPD and asthma in relation to smoking status and disease severity
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
Expression of MMP-8 protein in alveolar macrophages is related to bronchial asthma severity and treatment efficacy
Source: Annual Congress 2010 - Cell biology and immunology of lung disease
Year: 2010
Increased CCL18 serum levels in patients with pulmonary fibrosis which reflect disease severity
Source: Eur Respir J 2005; 26: Suppl. 49, 21s
Year: 2005
Elevated sputum BPIFB1 levels correlate with progression of chronic obstructive pulmonary disease
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
The relationship between the serum YKL-40 level and severity of asthma
Source: Annual Congress 2012 - Asthma management
Year: 2012
The role of Hs-CRP in evaluating asthma severity and asthma control
Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept